The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery

Last updated: December 11, 2024
Sponsor: Shanghai Tong Ren Hospital
Overall Status: Completed

Phase

N/A

Condition

Colorectal Cancer

Cancer

Colon Cancer

Treatment

ICG Guided surgery

conventional surgery

Clinical Study ID

NCT06508541
2024-06-001
  • Ages > 18
  • All Genders

Study Summary

Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age > 18 years,

  • confirmed diagnosis of primary CRC,

  • preoperative tumor stage of cT1 to cT4, N-/+, M0 as determined by contrast-enhancedcomputed tomography (CT),

  • no distant metastasis, -American Society of Anesthesiologists(ASA)Physical StatusClassification score of 1, 2, or 3-

Exclusion

Exclusion Criteria:

  • history of previous colorectal surgery, emergent surgery, or palliative resection;

  • pregnancy or breastfeeding;

  • allergy or history of an adverse reaction to ICG; and

  • severe mental disorder.

Study Design

Total Participants: 235
Treatment Group(s): 2
Primary Treatment: ICG Guided surgery
Phase:
Study Start date:
July 15, 2024
Estimated Completion Date:
October 01, 2024

Connect with a study center

  • Shanghai Tongren Hospital

    Changning, Shanghai 200336
    China

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.